CELLECTIS - ADR (CLLS) Stock Cash Flow
NASDAQ:CLLS - Nasdaq - US15117K1034 - ADR - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -100.73M | -116.83M | -98.69M | -125.11M | -97.48M | |||
| Depreciation Amortization | 18.95M | 18.52M | 18.43M | 16.57M | 9.82M | |||
| Change In Working Capital | 118.44M | 52.86M | -4.48M | -3.18M | -19.19M | |||
| Interest Paid | 566.00K | 333.00K | 332.00K | 355.00K | N/A | |||
| Taxes Paid | 342.00K | -371.00K | -87.00K | N/A | N/A | |||
| Other non cash items | 14.83M | 20.71M | -2.71M | 7.15M | 26.59M | |||
| OPERATING CASH FLOW | 51.49M | -24.75M | -87.44M | -104.56M | -80.26M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.85M | -1.07M | -2.44M | -19.74M | -52.97M | |||
| Other Investing Activity | -120.59M | -14.44M | -320.00K | 27.02M | -1.38M | |||
| INVESTING CASH FLOW | -122.43M | -15.51M | -2.76M | 7.28M | -54.34M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 7.04M | 13.48M | -6.60M | -12.46M | 17.56M | |||
| Stock Issued/Repurchased | N/A | 67.94M | -569.00K | 15.48M | 9.55M | |||
| Other Financing Activity | 58.70M | 1.45M | 8.32M | 44.51M | 210.00K | |||
| FINANCING CASH FLOW | 133.67M | 82.86M | 1.15M | 47.52M | 27.32M | |||
| Exchange Rate Effect | 1.93M | 884.00K | -3.36M | -5.75M | 7.91M | |||
| CHANGE IN CASH | 64.66M | 43.49M | -92.42M | -55.51M | -99.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 51.49M | -24.75M | -87.44M | -104.56M | -80.26M | |||
| Capital Expenditure | -1.85M | -1.07M | -2.44M | -19.74M | -52.97M | |||
| FREE CASH FLOW | 49.64M | -25.82M | -89.89M | -124.31M | -133.23M | |||
All data in USD